188 related articles for article (PubMed ID: 25744169)
1. Anti-RANKL treatment improves screw fixation in cancellous bone in rats.
Bernhardsson M; Sandberg O; Aspenberg P
Injury; 2015; 46(6):990-5. PubMed ID: 25744169
[TBL] [Abstract][Full Text] [Related]
2. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.
Aspenberg P; Agholme F; Magnusson P; Fahlgren A
Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557
[TBL] [Abstract][Full Text] [Related]
3. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
Wang Y; Huang P; Tang PF; Chan KM; Li G
J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
[TBL] [Abstract][Full Text] [Related]
4. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
[TBL] [Abstract][Full Text] [Related]
5. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
[TBL] [Abstract][Full Text] [Related]
6. Sol-gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia.
Linderbäck P; Areva S; Aspenberg P; Tengvall P
J Biomed Mater Res A; 2010 Aug; 94(2):389-95. PubMed ID: 20186735
[TBL] [Abstract][Full Text] [Related]
7. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
8. Experimental models for cancellous bone healing in the rat.
Bernhardsson M; Sandberg O; Aspenberg P
Acta Orthop; 2015; 86(6):745-50. PubMed ID: 26200395
[TBL] [Abstract][Full Text] [Related]
9. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
[TBL] [Abstract][Full Text] [Related]
10. Surface-bound bisphosphonates enhance screw fixation in rats--increasing effect up to 8 weeks after insertion.
Wermelin K; Tengvall P; Aspenberg P
Acta Orthop; 2007 Jun; 78(3):385-92. PubMed ID: 17611854
[TBL] [Abstract][Full Text] [Related]
11. Weak effect of strontium on early implant fixation in rat tibia.
Linderbäck P; Agholme F; Wermelin K; Närhi T; Tengvall P; Aspenberg P
Bone; 2012 Jan; 50(1):350-6. PubMed ID: 22108138
[TBL] [Abstract][Full Text] [Related]
12. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
13. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model.
Çankaya M; Cizmeci Şenel F; Kadioglu Duman M; Muci E; Dayisoylu EH; Balaban F
Int J Oral Maxillofac Surg; 2013 Sep; 42(9):1134-9. PubMed ID: 23522850
[TBL] [Abstract][Full Text] [Related]
14. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
Nakamura Y; Hayashi K; Abu-Ali S; Naito M; Fotovati A
J Bone Joint Surg Am; 2008 Apr; 90(4):824-32. PubMed ID: 18381321
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined therapy of alendronate and low-intensity pulsed ultrasound on metaphyseal bone repair after osteotomy in the proximal tibia of aged rats.
Aonuma H; Miyakoshi N; Kasukawa Y; Kamo K; Sasaki H; Tsuchie H; Segawa T; Shimada Y
J Bone Miner Metab; 2014 May; 32(3):232-9. PubMed ID: 23921832
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
Lloyd SA; Morony SE; Ferguson VL; Simske SJ; Stodieck LS; Warmington KS; Livingston EW; Lacey DL; Kostenuik PJ; Bateman TA
Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
[TBL] [Abstract][Full Text] [Related]
17. Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants.
Jensen TB; Bechtold JE; Chen X; Søballe K
J Orthop Res; 2007 Jun; 25(6):772-8. PubMed ID: 17318896
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate.
Szymczak J; Bohdanowicz-Pawlak A
Horm Metab Res; 2013 Sep; 45(10):759-64. PubMed ID: 23888411
[TBL] [Abstract][Full Text] [Related]
19. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats.
Bradaschia-Correa V; Moreira MM; Arana-Chavez VE
Cell Tissue Res; 2013 Jul; 353(1):79-86. PubMed ID: 23636419
[TBL] [Abstract][Full Text] [Related]
20. Do bisphosphonates inhibit direct fracture healing?: A laboratory investigation using an animal model.
Savaridas T; Wallace RJ; Salter DM; Simpson AH
Bone Joint J; 2013 Sep; 95-B(9):1263-8. PubMed ID: 23997143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
